Based on experimental studies and small-scale clinical studies, nondihydropyridine calcium channel blockers, diltiazem has also been shown to slow the rate of progression of DN, whereas dihydropyridines have varied effects on albumin excretion [163]. Here, ALB is linked to liver dysplastic nodule.